Bevacizumab/Carboplatin/Paclitaxel Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bevacizumab, carboplatin and paclitaxel that can be used in the treatment of endometrial, ovarian, fallopian tube and primary peritoneal, vaginal, vulvar and cervical cancers and non-small cell lung cancer (NSCLC).

**Synonyms:** - Carbo-Taxol-Avastin Regimen - Carboplatin and Paclitaxel (CP) and Bevacizumab - Carboplatin and Paclitaxel (CP) and Bevacizumab-adcd - Carboplatin and Paclitaxel (CP) and Bevacizumab-awwb - Carboplatin and Paclitaxel (CP) and Bevacizumab-aybi - Carboplatin and Paclitaxel (CP) and Bevacizumab-bvzr - Carboplatin and Paclitaxel (CP) and Bevacizumab-equi - Carboplatin and Paclitaxel (CP) and Bevacizumab-maly - Carboplatin and Paclitaxel (CP) and Bevacizumab-onbe - Carboplatin and Paclitaxel (CP) and Bevacizumab-tnjn - Carboplatin-Paclitaxel-Bevacizumab - Carboplatin-Taxol-Bevacizumab - Carboplatin-Taxol-Bevacizumab Regimen - Carboplatin/Paclitaxel/Bevacizumab - carboplatin-Taxol-bevacizumab regimen - carboplatin-paclitaxel-bevacizumab regimen